Investigators from University of Chicago Medicine Release New Data on Glycopeptide Antibiotics (Fidaxomicin Versus Oral Vancomycin for clostridioides Difficile Infection Among Patients At High Risk for Recurrence Based On Real-world

Source :: Obesity, Fitness & Wellness Week. November 9, 2024, p2382.
Publication Year :: 2024
Abstract: 2024 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Glycopeptide Antibiotics have been [...]

Subjects :: University of Chicago
Fidaxomicin -- Health aspects
Infection -- Health aspects
Antibacterial agents -- Health aspects
Physical fitness -- Health aspects

Tools